Details for New Drug Application (NDA): 021283
✉ Email this page to a colleague
The generic ingredient in DIOVAN is hydrochlorothiazide; valsartan. There are thirty-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; valsartan profile page.
Pharmacology for NDA: 021283
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 021283
Suppliers and Packaging for NDA: 021283
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DIOVAN | valsartan | TABLET;ORAL | 021283 | NDA | Novartis Pharmaceuticals Corporation | 0078-0358 | 0078-0358-34 | 90 TABLET in 1 BOTTLE (0078-0358-34) |
DIOVAN | valsartan | TABLET;ORAL | 021283 | NDA | Novartis Pharmaceuticals Corporation | 0078-0359 | 0078-0359-34 | 90 TABLET in 1 BOTTLE (0078-0359-34) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 80MG | ||||
Approval Date: | Jul 18, 2001 | TE: | AB | RLD: | Yes | ||||
Regulatory Exclusivity Expiration: | Apr 19, 2024 | ||||||||
Regulatory Exclusivity Use: | NEW PATIENT POPULATION |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 160MG | ||||
Approval Date: | Jul 18, 2001 | TE: | AB | RLD: | Yes | ||||
Regulatory Exclusivity Expiration: | Apr 19, 2024 | ||||||||
Regulatory Exclusivity Use: | NEW PATIENT POPULATION |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 320MG | ||||
Approval Date: | Jul 18, 2001 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021283
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | DIOVAN | valsartan | TABLET;ORAL | 021283-001 | Jul 18, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | DIOVAN | valsartan | TABLET;ORAL | 021283-003 | Jul 18, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | DIOVAN | valsartan | TABLET;ORAL | 021283-004 | Aug 14, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | DIOVAN | valsartan | TABLET;ORAL | 021283-003 | Jul 18, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | DIOVAN | valsartan | TABLET;ORAL | 021283-002 | Jul 18, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | DIOVAN | valsartan | TABLET;ORAL | 021283-002 | Jul 18, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription